| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 174,978 | 205,056 | 190,273 | | Cost of Revenue | 150,805 | 148,540 | 140,170 | | | Gross Profit | 24,173 | 56,516 | 50,103 | | | Operating Expenses | | Research Development |
-
|
-
| 8,838 | | Selling General and Administrative | 35,665 | 40,818 | 31,265 | | Non Recurring | 2,118 |
-
| (24) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (13,610) | 15,698 | 10,024 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 829 | 3,503 | 4,162 | | Earnings Before Interest And Taxes | (12,781) | 19,201 | 14,186 | | Interest Expense | 173 | 93 | 63 | | Income Before Tax | (12,954) | 19,108 | 14,123 | | Income Tax Expense | (4,156) | 8,873 | 6,908 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,798) | 10,235 | 7,215 | | | Non-recurring Events | | Discontinued Operations | 400 | 10,859 | 24,186 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,398) | 21,094 | 31,401 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,398) | $21,094 | $31,401 |
|
0.49% Nasdaq 
0.10 (1.44%) 
Income Statement
